Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-15

Clinical Trial Update: DexmedetOmidine Complement Treats Chronic insOmnia and Improves Circadian Rhythm (DOCTOR) [NA]

View source ↗

Summary

A completed clinical trial evaluated dexmedetomidine as a complementary treatment for chronic insomnia and to improve circadian rhythm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Ruijin Hospital | Conditions: Chronic Insomnia | NA | Status: COMPLETED